Clinical Trial Update: Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of Phase 2 and Phase 3 trials evaluating RP-G28 in adults with lactose intolerance, highlighting efficacy, safety, and tole…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactose Intolerance

Drugs mentioned

• RP-G28

Snippet

Sponsor: Ritter Pharmaceuticals, Inc. | Conditions: Lactose Intolerance | Phase 2, Phase 3 | Status: COMPLETED